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Recent epidemiologic studies suggest that cigarette smoking may increase the risk of 
hepatocellular carcinoma (HCC), yet inconsistent dose-response relationships still exist with this 
association. We examined whether cigarette smoking was associated with HCC risk and 
explored their dose-response relationship in a case-control study including 590 incident HCC 
cases and 784 hospital controls in Xiamen, China. Comparisons of HCC cases with hospital 
controls were conducted for each of the four measures of exposure levels of cigarette smoking 
- age started smoking, years smoked, cigarettes per day, pack-years in lifetime. After 
adjustment for demographic factors (sex, age, education, and income level) and alcohol 
drinking history (lifetime spirit-equivalents intake), no significantly elevated HCC risk was found 
associated with cigarette smoking in terms of any of these four measures of exposure levels, 
nor did we demonstrate the dose-response relationship, either in men or in population (women 
and men together). Comparisons were also conducted for second-hand smoking using “hours of 
exposure per week” as the measure of exposure levels, but we did not find significant 
association after adjustment either. Further studies are needed to explore the association 
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Liver cancer is the sixth most common cancer and the third most common cause of death from 
cancer worldwide, with an estimated 748,000 new cases and 696,000 deaths in 2008 (Ferlay J, 
2010). Nearly 85% of these cases occur in less developed countries, with China alone 
accounting for more than 50% of the total (Ferlay J, 2010). The estimated age standardized 
rates (ASRs, per 100,000) of liver cancer incidence in 2008 are 16.0 and 6.0 for men and women 
respectively (Ferlay J, 2010).  
There is wide variation in international liver cancer incidence rates: generally, the highest rates 
are found in Asia and West and Central Africa, and the lowest in Europe, Oceania, and North 
America (Jemal A, 2010). International variation in liver cancer rates is largely explained by the 
distribution of chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, with HBV 
infection generally dominating in high-risk areas, including Asia and Sub-Saharan Africa, and 
HCV infection dominating in low-risk areas, including most parts of Europe and North America. 
Other known risk factors that contribute to the international variations in liver cancer rates 
include dietary aflatoxin exposure, alcohol-related cirrhosis, fatty liver disease, obesity, and 
smoking (Chuang SC, 2009).   
Liver cancer incidence rates continue to increase in some low-risk parts of the world (Western 
Europe, North America, and Oceania) whereas they are decreasing in some of the highest risk 
countries in Asia, based on the analysis of 1993-2002 IARC’s Cancer Incidence in Five Continents 
(CI5) data (Jemal A, 2011). The decrease in Asian countries such as China is thought to reflect 
reduction in transmission of HBV through improved hygienic and sanitary conditions and 
reduction in contamination of food with aflatoxins through better food storage system; and 
infant hepatitis immunization programs implemented over the past two decades have also 
been shown to decrease the trend in children and adolescents in this area (Jemal A, 2010). 
Despite this, the incidence rates in Asian countries are still twice as high as those in Africa and 
more than four times as high as rates in North America (Jemal A, 2011).  
7 
 
The vast majority of primary liver cancers, 75% to 90%, are hepatocellular carcinomas (HCC), 
which are malignant tumors of liver parenchymal cells (Jemal A, 2011). The most common risk 
factors include chronic HBV/HCV infection, alcohol intake, and aflatoxin exposure. The risk of 
HCC in people infected with HBV/HCV is up to 20 times higher than in those who are not (IARC, 
Hepatitis Viruses, 1994). Both HBV and HCV increase the risk of HCC through their promotion of 
cirrhosis, although HBV carriers are at risk of HCC even in the absence of cirrhosis (El-Serag HB, 
2007).  Worldwide, approximately 85% (HBV, 54%; HCV, 31%) of HCC can be attributed to 
hepatitis virus infection (Parkin, 2006). Other risk factors of HCC include smoking, diabetes, and 
obesity.  
Historically, the primary risk factors for liver cancer in China have been HBV infection and 
dietary aflatoxin exposure, and these two factors have been shown to have a synergistic effect 
on HCC (Bosch FX, 2004). Prevention strategies had been implemented to tackle these two risk 
factors over the past few decades: infant HBV immunization programs, improved sanitary 
conditions, and reduction in consumption of foods contaminated with aflatoxin, which led to 
reductions in HCC incidence in China. However, the association between HCC risk and other risk 
factors such as smoking has not been well established among this population.  As HCC 
development is a multistage process, it is influenced by other environmental and genetic 
factors, and tobacco use has been suspected as one such candidate (Chen CJ, 1997).  
Several constituents of tobacco smoke are known liver carcinogens in humans and 
experimental animals (Lee YC, 2009). N-Nitrosodimethylamine is carcinogenic in many species 
including mice, rats and monkeys, and is known to lead to the development of liver tumors 
(IARC, Some N-Nitroso compounds, 1978). 4-Aminobiphenyl also produces liver tumors in mice. 
An association between 4-aminobiphenyl–DNA adduct levels in the liver, which were found to 
be higher in the blood of smokers than of non-smokers, and HCC in Taiwanese patients has 
been reported (IARC, 1978) (Dooley KL, 1992). Vinyl chloride has been classified as carcinogenic 




Data on smoking as a risk factor for HCC had been conflicting.  Early cohort studies from the 
USA (Hammond, 1966), the Philippines (Basa GF, 1977), Japan (Hirayama, 1989) and China (Tu 
JT, 1985) reported increased risks of liver cancer among smokers and some evidence of a dose–
response relationship (Hirayama, 1989), albeit in some studies this was observed only in HBV 
carriers (Tu JT, 1985). In 2004, IARC Monograph on tobacco smoke (IARC, Tobacco smoke and 
involuntary smoking, 2004) concluded that there is now sufficient evidence that tobacco 
smoking causes liver cancer. However, at about the same time, the US Surgeon General’s report 
on the health consequences of smoking (The health consequences of smoking: a report of the 
Surgeon General , 2004) concluded that the evidence is suggestive but not sufficient to infer a 
causal relationship between smoking and liver cancer, mainly because exposures to other risk 
factors that may act as confounders complicated the evaluation (Lee YC, 2009).  
The debate on the associate of smoking and liver cancer seemed to be settled at the end of the 
first decade of this century. Along with Hepatitis B or C viruses (HBV and HCV) infection, alcohol 
drinking, and aflatoxin, smoking has been included as the established risk factors of liver cancer 
(London WT, 2006). A meta-analysis conducted by Gandini et al. on smoking and liver cancer 
concluded an overall OR of 1.56 (95% CI 1.29–1.87) comparing current-smokers to never-
smokers and of 1.49 (95% CI 1.06–2.10) comparing former smokers to never smokers. The 
associations among current smokers appeared to be consistent with the overall RR regardless 
of region, study design, study sample size, and publication period (S. Gandini, 2008). A meta-
analysis conducted by Lee et al. in 2009 supported the association between cigarette smoking 
and liver cancer risk. The risk appeared to be moderate, with a ~1.5 fold increase for current 
smoking, which supported the conclusion by the IARC Monograph (Lee YC, 2009). In 2010, 
Chuang et al. reported their meta-analysis results that cigarette smoking had a measureable 
effect on HCC risk, and also suggested a synergistic interaction between cigarette smoking and 
HBV/HCV infection (Chuang SC, 2010). Recent studies also suggested smoking as a risk factor of 
HCC. A case-control study nested in a European cohort reported a significant association 
between cigarette smoking and HCC risk (OR=1.98 for former smoking and OR=4.55 for current 
smoking) in 2011, and surprisingly an almost 50% attributable risk for smoking, far higher than 
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the attributable risk of HBV (13%) and HCV (20.9%) infection in population (Trichopoulos D, 
2011).  
Although the effect of cigarette smoking on the risk of HCC has been established, the dose–
response relationship between smoking and HCC risk has been unclear in most epidemiologic 
studies, particularly, in case–control studies (Tanaka K, 2006). Tanaka et al. reported in 1995 
that current, but not former, heavy smoking was an independent risk factor for HCC (RR = 4.9) 
in a case–control study using hospitalized patients (Tanaka H, 1995). Megumi et al reported in 
2008 that no dose–response relationship was evident for pack-years during lifetime, yet more 
recent cigarette consumption such as pack-years during the last 5 years was significantly 
associated with HCC risk in a dose-dependent manner in the comparison of HCC cases with 
Chronic Liver Disease (CLD) patients (Megumi Hara, 2008), and suggested the possibility that a 
change in recent smoking habit may have a large effect on smoking-HCC relations, thereby 
distorting dose–response relationships with pack-years during lifetime or cigarette 
consumption measured in the remote past. A case-control study in the U.S. reported in 2012 
that cumulative tobacco use was an independent predictor of HCC risk for patients with chronic 
liver disease (OR 1.7 for smoking over 11,000 packs of cigarettes over lifetime) (Nghi B. Ha, 
2012). In the meta-analysis done by Lee et al in 2009, a positive dose–response trend was 
observed for the number of cigarettes smoked per day, however, there was substantial 
heterogeneity for the overall dose–response relationship (Lee YC, 2009). The evidence of 
heterogeneity disappeared when the dose–response relationship was examined by type of 
control population. The dose–response relationship for studies with hospital controls was 
either null or negative, whereas that for studies with population controls was positive (Lee YC, 
2009). Thus, type of controls in case–control studies is one likely source of heterogeneity (Lee 
YC, 2009).  
Secondhand smoke is the combination of smoke emitted from the burning ends of a tobacco 
product (side stream smoke) and the smoke exhaled from the lungs of tobacco users (exhaled 
mainstream smoke) (Centers for Disease Control, 1986). More than 60 substances contained in 
second-hand smoke are known or suspected to cause cancer (Environmental Protection 
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Agency, 1992). Among them, Vinyl chloride has been classified as carcinogenic to humans with 
sufficient evidence for causing angiosarcoma of the liver and HCC (Wang LY, 1998). Yuan et al. 
provided evidence demonstrating that side stream smoke, a major component of second-hand 
smoke, may accelerate the development of experimental  non-alcoholic fatty disease (NAFLD) 
(Yuan H, 2009), a potential risk factor of HCC. However, no direct link has been established 
between second-hand smoking and liver cancer in epidemiology.  
In an attempt to better understand the association between cigarette smoking and the HCC 
risk, as well as the dose-response relationship between them, we conducted a case-control 
study in Xiamen, China, to compare the smoking history between HCC cases and hospitals 
controls. In particular, we are looking at four measures of exposure levels of cigarettes smoking 
- age started smoking, years smoked, number of cigarettes smoked per day, and pack-years of 
smoking in lifetime, and one measure of exposure levels of second hand smoke – hours of 
second hand smoke exposure per week. A better understanding of the magnitude of the effect 
of cigarette smoking and the dose-response relationship may have important public health 





Materials and methods  
Subjects 
HCC cases  
Patients with HCC were eligible (i) if primary liver cancer was diagnosed between February 2007 
and May 2010, (ii) if they were Chinese and residents of Xiamen City, Fujian Province, China, for 
at least 10 years. Eligible patients were identified among those who were admitted to Xiamen 
Hospital of T.C.M, Xiamen University Zhong Shan Hospital, the Third Hospital of Xiamen, or 
People's Army the 174th Hospital, the four major hospitals in Xiamen City. A total of 620 eligible 
patients were located, with 590 cases (95.2%) completed participation. The diagnosis of HCC 
was based on Chinese Society of Liver Cancer Primary Liver Cancer Diagnostic Criteria 2001.   
Hospital controls  
Controls were recruited from among patients admitted to the spine bone surgical department 
and the trauma surgical department in the same four hospitals in the same period of time. 
Control patients were eligible if they were free of tumor and the selection criterion (ii) was met. 
A total of 850 eligible patients were located, with 784 controls (92.2%) completed participation. 
The 784 hospital controls were diagnosed as follows: diseases of digestive system (n=74, 9.4%), 
diseases of genitourinary system (n=92, 11.7%), diseases of musculoskeletal system (n=534, 
68.1%), endocrine and metabolic diseases (n=55, 7.0%), diseases of respiratory system (n=7, 
0.9%), diseases of blood (n=7, 0.9%), undiagnosed (n=15, 1.9%).   
The study protocol was approved by the Institutional Review Board (IRB), and written informed 
consent to the use of information for this study was obtained from all subjects.  
Interviews  
Medical staff interviewed recent diagnosed patients in hospitals in person using a standardized 
questionnaire that requested demographic data, habits of alcohol intake, cigarette use, and 
second hand smoke exposure one year prior to the interview.  
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Queries about smoking habit first ascertained current smoking status (ever smoke; if still 
smoke).  We defined “ever smoke” as having been smoking at least one cigarette per day for at 
least one month, and “still smoke” as still smoking. Then, those who have ever smoked were 
asked to provide the number of cigarettes they usually smoked per day, age of starting and 
quitting smoking, and years of smoking. Pack-years of cigarettes in lifetime was calculated as 
pack-years=number of cigarettes per day*30 days*12 months*years of smoking/7200). 
Queries about second hand smoke exposure were first ascertained the current exposure status 
(exposed to second hand smoke or not). Then, those who have been exposed were asked about 
how many hours per week they have been in an environment where someone else is smoking.  
Queries regarding alcohol use first ascertained current drinking status (ever drink alcohol; if still 
drink alcohol). We defined “ever drink alcohol” as having been drinking alcohol at least once 
per month for at least one year, and “still drink alcohol” as still drinking alcohol. Then, those 
who have ever drunk alcohol were asked to provide their age of starting and quitting drinking, 
and years of drinking alcohol, and the usual frequency and amount of alcohol use. The amount 
of alcohol use was reported in Liang (a Chinese unit, which equals to 50 grams) for high-degree 
Chinese spirit, low-degree Chinese spirit, Chinese yellow or rice wine, red or white wine, 
champagne or sparkling wine, and beer. Based on the relative alcohol concentration of each 
drink (Zheng TZ, 1990), we estimated the daily intake of alcohol in spirit-equivalent as high-
degree Chinese spirit*1.4, low-degree Chinese spirit *1, Chinese yellow or rice wine/2, red or 
white wine/3, champagne or sparkling wine/5, and beer/8.  
Statistical analysis  
Unconditional logistic regression models were used to estimate the odds ratios (ORs) of HCC 
with their 95% confidence intervals (95% CIs) for cigarette smoking and second-hand smoking 
with adjustment for potential confounders. Smoking status were determined as never verse 
ever smokers. Measures of exposure levels of cigarette smoking factors include: age started 
smoking (never started, started 21+, and started between 1-20 years old); years smoked (0, 1-
21, 22-31, and 32+ years); cigarettes per day (0, 1-19, and 20+); pack-years of smoking in 
lifetime (0, 1-17, 18-31, and 32+). Second hand smoke exposure factors include: exposure 
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status (unexposed and exposed); hours of exposure per week (0, 1-20, and 21+). Potential 
confounders include: age (0-39, 40-59, and 60+); sex (female and male); education (0-9 and 10+ 
school years); annual income (0-18000 and 18001+ RMB); alcohol drinking (0, 1-203, 204-703, 
and 704+ kilograms of spirit-equivalents intake in lifetime).  
The corresponding logistic models were also used to assess the linear trends of HCC risk across 
exposure levels: ordinal categories of each of the following variables - age started smoking 
years of smoking, cigarettes per day, pack-years, and hours of second hand smoking per week – 
were included in the logistic model with covariates respectively.   
Among 1374 subjects (590 cases and 784 controls), 50 subjects (18 cases and 32 controls) with 
smoking related missing data were excluded from the analysis.  
As female smokers (n=7 out of 375 subjects) and female subjects exposed to second-hand 
smoke (n=14 out of 375 subjects) were very few, further analyses were only conducted in 






Basic characteristics of study subjects 
Tables 1.1-1.3 show the basic characteristics of study subjects in population, men, and women 
respectively. In population, as compared with control group, HCC cases presented higher 
proportion of males (p<.001), younger subjects (p<.001), lower education level (p<.001),  lower 
annual income (p<.001),  drinking alcohol (p<.001), consuming more alcohol during lifetime 
(p<.001), exposed to second-hand smoking (p<.001) and being exposed with longer hours per 
week (p<.001), smoking cigarettes (p<.001), younger age started smoking (p<.001), longer years 
smoked (p<.001), and smoking more cigarettes per day (p<.001) and in lifetime (p<.001). Similar 
situation was also found in men. In women, since there were only 7 smokers and 14 subjects 
who had ever been exposed to second hand smoke, further analysis will be not been performed 
in this group.  
Cigarette Smoking 
The associations of HCC risk with cigarette smoking for population and for men are explored in 
Tables 2.1 and Table 2.2, respectively.  
In population, before adjustment for demographic factors (sex, age, education level, and annual 
income) and alcohol drinking (lifetime intake of spirit-equivalents), cigarette smoking showed 
significantly moderate effect on the HCC risk. Compared to never smokers, the HCC risk was 
elevated for smokers (OR 1.93, 95% CI 1.55-2.41). In terms of the four measures of exposure 
levels of cigarettes smoking – age started smoking, years smoked, cigarettes smoked per day, 
and pack-years, all showed significantly moderate effect on the HCC risk. Compared to never 
smokers, the HCC risk was elevated for those starting smoking 21+ years old (OR 1.63, 95% CI 
1.22, 2.17) and 1-20 years old (OR 2.20, 95% CI 1.69, 2.87), smoking for 1-21 (OR 2.25, 95% CI 
1.64, 3.07) and 32+ years (OR 2.89, 95% CI 1.04, 4.08), smoking 1-19 (OR 1.54, 95% CI 1.15, 
2.06) and 20+ cigarettes (OR 2.29, 95% CI 1.76, 2.97) per day, and pack-years 1-17 (OR 1.43, 
95% CI 1.05, 1.96), 18-31 (OR 2.03, 95% CI 1.49, 2.77) and 32+ (OR 2.59, 95% CI 1.85, 3.62) in 
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lifetime. All these four measures of levels of exposure showed significant dose-response 
relationships, with tests for linear trend giving p trend<.001. However, after adjustment for 
demographics and drinking, the effect of cigarette smoking was not significant any more, and 
none of the measures of exposure levels showed significant dose-response relationship.  
Interestingly, after excluding socioeconomic factors – education and income levels – from the 
adjustment, the estimated HCC risk changed significantly for some of the measures, giving OR 
1.94 (95% CI 1.29-2.91) for years of smoking 32+ and OR 1.71 (95% CI 1.15-2.53) for pack-years 
32+, and showing a significant linear trend for pack-year of smoking over lifetime (p 
trend=.010).  
In men, before adjustment for demographic factors (age, education level, and annual income) 
and alcohol drinking (lifetime intake of spirit-equivalents), the HCC risk was elevated for 
smokers (OR 1.20, 95% CI 0.92-1.56), however, the effect was not significant. In terms of the 
four measures of exposure levels of cigarettes smoking, three of them - years smoked, 
cigarettes smoked per day, and pack-years - showed significantly moderate effect on the HCC 
risk. Compared to never smokers, the HCC risk was elevated for those smoking for 1-21 (OR 
1.47, 95% CI 1.04, 2.08) and 32+ years (OR 1.75, 95% CI 1.20, 2.53), smoking 20+ cigarettes per 
day (OR 1.38, 95% CI 1.03, 1.86), and pack-years 32+ (OR 1.57, 95% CI 1.09, 2.25). Two 
measures of levels of exposure showed significant dose-response relationships, with tests for 
linear trend giving p trend=.034 for cigarettes per day and p trend=.012 for pack-years. 
However, after adjustment for demographics and drinking, only the highest category of the 
“years smoked” (32+ years) remained significant (OR 1.56, 95% CI 1.02, 2.39), and none of the 
measures showed significant dose-response relationship.   
After excluding socioeconomic factors – education and income levels – from the adjustment, 
the estimated HCC risk changed significantly for some of the measures, giving OR 1.42 (95% CI 
1.03-1.95) for those smoking 20+ cigarettes per day and OR 1.72 (95% CI 1.16-2.54) for pack-
years 32+, and showing significant linear trends across these two measurements (p trend=.033 
and .008, respectively).  
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The influence of socioeconomic status (SES) on the association between cigarette smoking and HCC risk 
in this population  
The multivariate logistic models assessing HCC risk according to pack-years of smoking with 
adjustment before and after excluding SES factors are shown in Table 2.3 and Table 2.4, 
respectively. Educational and annual income level seem to play an important role in 
determining HCC risk in this population, as the adjusted odds ratio of HCC for those having 
education less than 10 years (compared to 10+ years) is 2.11 (95% CI 1.61-2.76) in population 
and 1.70 (95% CI 1.27-2.28) in men, and the adjusted odds ratio of HCC for those having annual 
income less than 18000 RMB (compared to 18001+ RMB) is 2.26 (95% CI 1.73-2.96) in 
population and 1.87 (95% CI 1.38-2.51) in men. When excluding education and income from 
this model, the effect of pack-years changed significantly (odds ratio associated with pack-years 
32+ is 1.71, 95% CI 1.15-2.53), and test for linear trend became positive (p=.010), suggesting a 
significant dose-response relationship. Given these results, it seemed that SES factors 
(education and income) might change the association between cigarette smoking and HCC risk.  
To further explore the influence of socioeconomic status on HCC risk, we estimated stratified 
odds ratios associated with pack-years of smoking with logistic regression. The four strata are 
as follow: education low/income low, education low/income high, education high/income low, 
and education high/income high. However, quasi-complete data separation was detected in 
three of the four strata, in which the odds ratios estimation is questionable. Thus, we did not 
test heterogeneity of the HCC risk across these four strata; whether or not the SES factors could 
influence the association between cigarette smoking and HCC risk cannot be determined in this 
study.  
Second-hand smoking  
The association of HCC risk with second-hand smoking for population and for men is explored in 
Tables 3.1 and Table 3.2, respectively.  
In population, before adjustment for demographic factors (sex, age, education level, and annual 
income) and alcohol drinking (lifetime intake of spirit-equivalents), second-hand smoking 
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showed significantly moderate effect on the HCC risk. Compared to those free from second 
hand smoking exposure, the HCC risk was elevated for those exposed to second hand smoke 
(OR 1.81, 95% CI 1.44-2.26). The exposure level – hours per week – showed significant dose-
response relationship with test for trend giving p trend <.001. However, the effect was no 
longer significant after adjustment for demographics and alcohol drinking, and the dose-
response relationship was not significant either (p trend =.207). The significance level did not 
change much after excluding SES factors from the adjustment.  
In men, the effect of second-hand smoking was not significant either before or after adjustment 
for demographics (age, education level, and annual income) and drinking (lifetime intake of 
spirit-equivalents. The exposure level – hours per week – did not show significant dose-
response relationship either before or after adjustment (p trend=.416 and .508, respectively). 
The significance level for odds ratios and linear trend did not change much after excluding SES 





In this study, neither cigarette smoking nor second hand smoke exposure significantly elevated 
the risk of HCC after adjustment for demographics and alcohol drinking, nor had the dose-
response relationship been detected. The following points may partly explain the lack of 
significant results of this study, and are discussed here.  
The effect of recent versus remote cigarette smoking habit  
Some studies suggested that a change in recent smoking habit may have a large effect on 
smoking-HCC relationship, thereby distorting dose-response relationships with pack-years 
during lifetime or cigarette consumption measured in the remote past.  
Tanaka et al. in 1995 reported that current, but not former, heavy smoking was an independent 
risk factor for HCC in a case-control study using hospitalized controls (Tanaka H, 1995). Megumi 
et al. in 2008 further explored the role of recent smoking habit in HCC development. In the 
case-control study using both a traditional hospital control group and a chronic liver disease 
(CLD) patient control group, Megumi et al. demonstrated a significantly increased risk of HCC 
for current smokers in comparison of HCC cases with CLD controls, but not with hospital 
controls. Interestingly, the dose-response relationship - in terms of pack-years of smoking in 
lifetime - was not evident against either control group, but it became clearer for recent 
cigarette use in comparison of HCC cases with CLD controls: regarding cumulative cigarette 
consumption during the last 5 years, adjusted odds ratios (and 95% confidence intervals) for 1-4 
and 5+ pack-years relative to no use were 1.9 (1.1-3.6) and 2.8 (1.5-5.2) (P trend = 0.003), 
respectively (Megumi Hara, 2008). Hirayama and Tsukuma et al. also suggested that cigarette 
smoking may be involved in end-stage development of liver cancer, such as cirrhosis to HCC.  
Given these results, cigarette smoking may play a crucial role in the late stage of HCC 
development, and analysis of the effect of recent smoking habit may be helpful for our study. 
However, cigarette smoking habits in our study were only recorded in a lifetime-average 
manner, and information of recent smoking habits was not available. With regard to the HCC 
risk associated with current versus former smokers, our study gave an unreliable result: 
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compared to never smokers, the odds ratio of HCC for former smoker is 5.45 (95% CI 2.90-
10.24), while for current smoker it is 0.62 (95% CI 0.45-0.85), after adjustment for 
demographics and alcohol drinking (the data are not reported in the above tables). This 
discrepancy from general knowledge and literatures on cancer research suggested an obvious 
influence of the change of behavior due to disease prognosis or diagnosis on the study result. 
As information of disease stages at the time of quitting smoking (behavior change) was not 
recorded in our study, the effect of current smoking cannot be identified.  
The influence of HBV/HCV infections  
Whether or not the association between cigarette smoking and HCC risk would be modified by 
HBV/HCV infection is still unclear. In the meta-analysis conducted by Chuang et al. in 2010, 
although a synergistic interaction between cigarette smoking and HBV/HCV infection was 
suggested, data from individual studies on the interaction between HBV infection and smoking 
are not consistent (Chuang SC, 2010).  
Some studies observed an association between cigarette smoking and HCC only among HBV-
negative persons: a case-control study in Hong Kong reported in 1982 that significant 
association with cigarette smoking was found among primary liver cancer cases who were 
negative for HBsAg (Lam KC, 1982); a case-control study in Greece reported in 1987 that a 
statistically significant dose-response relationship of tobacco smoking was found among HBsAg-
negative HCC but not among HBsAg-positive HCC cases (Trichopoulos D, 1987); and a cohort 
study in Taiwan reported in 2003 that HCC risk was significant for cigarette smokers among 
HBsAg-negatives and there was a significant gradient of HCC risk with the duration of cigarette 
smoking among HBsAg-negative subjects (Wang LY, 2003).  
Some studies reported the association in HBV carriers: a study in Japan reported in 1984 that 
heavy smoking was found associated with a higher risk of liver cancer among HBsAg-positive 
subjects (Oshima A T. H., 1984); and a study in Italy reported in 2006 that current smoking was 
unrelated to HCC risk among HBsAg negatives and anti-HCV negatives, but seemed to enhance 
the adverse effect of hepatitis virus (S. Franceschi, 2006).  
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Other studies reported no interaction between smoking and HBV infection: a study in Japan 
reported in 2000 that there was no significant additive interaction between HBsAg status and a 
history of cigarette smoking (Mori M, 2000); and a cohort study in Korea reported in 2004 that 
cigarette smoking and HBV infection were independently associated with increased risk of 
mortality from HCC but did not interact synergistically (Jee SH, 2004).  
By contrast, most studies observed an interaction between cigarette smoking and HCV infection 
on the risk of HCC (Chuang SC, 2010). Studies in Taiwan (Yu MW, 1991) (Sun CA, 2003), Japan 
(Hassan MM, 2008), and American (Fujita Y, 2006) reported that cigarette smoking was 
associated with significantly elevated risk of developing HCC among anti-HCV positive subjects.  
Due to the lack of information on HBV/HCV infection in the current stage of our study, we could 
not verify if HBV/HCV infection would modify the association between cigarette smoking and 
HCC risk, nor could we explore the synergistic effect of hepatitis virus infection and cigarette 
smoking in HCC development. If the association between cigarette smoking and HCC risk is 
indeed dependent on hepatitis virus infection, then it is not unexpected to fail to detect the 
existence of a significant effect of cigarette smoking on HCC risk or a dose-response relationship 
in a pooled population consist of individuals with or without hepatitis infections as it is in our 
study.  
Theories were proposed for the role of cigarette smoking in liver carcinogenesis and its 
potential interaction with viral infection. Cigarette smoke contains several chemicals that are 
metabolized and activated as carcinogens in the liver (Staretz ME, 1997) and it can therefore 
act as an initiator in the liver carcinogenesis, whereas HBV and HCV mainly act as a promoter 
through chronic inflammation and cell proliferation through chronic hepatitis and liver cirrhosis 
(IARC, Hepatitis viruses, 1994). In addition, cigarette smoking may contribute to the progression 
from chronic HBV and HCV infection to HCC.  
The effect of second-hand smoking  
The ability of assessing the effect of second-hand smoking of this study was limited: as there 
are only 13 out of 733 never smoker subjects exposed to second-hand smoking, we did not 
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estimate the HCC risk associated with second-hand smoking among never smokers; rather, we 
assessed it among never and ever smokers as a whole. As most subjects who were exposed to 
second-hand smoking were also exposure to active cigarette smoking, it is difficult to 
differentiate the effects of these two exposures.  
The influence of socioeconomic status (SES) 
SES factors – education and income levels – showed independent effects in predicting HCC risk 
among this population. However, whether the effects of SES would modify the association 
between cigarette smoking and HCC risk is not clear in this study. Education and income level 
might partially reflect the awareness of and the potential exposures to HCC risk factors such as 
dietary aflatoxin, HBV/HCV infection, and other liver diseases, however, none of these factors 
were captured in the current study. Further investigation is needed to illustrate whether 
cigarette smoking has effect on HCC risk in this population, whether it exert its effect 
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Appendix: Tables  
Table 1.1 Basic characteristics of study subjects among population  
Factors   Population (N=1324)  
  Cases (N=572) Controls (N=752) p-value* 
  n (%) n (%)  














































































































































Table 1.2 Basic characteristics of study subjects among men 
Factors   Male (N=949)  
  Cases (N=484) Controls (N=465) p-value*  
  n (%) n (%)  










































































































































Table 1.3 Basic characteristics of study subjects among women 
Factors   Female (N=375)  
  Cases (N=88) Controls (N=287) p-value*  
  n (%) n (%)  















































































Table 2.1 Odds ratios of HCC according to smoking among population  




OR (95% CI)  
Unadjusted 
    (95% CI)  
Adjusted* 
    (95% CI) 
Adjusted** 
  n (%) n (%)    





264 (46.2)  
308 (53.9) 
469 (62.4)  
283 (37.6) 
1.00 
1.93 (1.55, 2.41) 
1.00 
0.90 (0.66, 1.21) 
1.00 
1.11 (0.84, 1.47) 














1.63 (1.22, 2.17) 
2.20 (1.69, 2.87) 
p trend<.001 
1.00 
0.87 (0.62, 1.24) 
0.92 (0.65, 1.29) 
p trend=.616 
1.00 
1.03 (0.73, 1.44) 
1.18 (0.85, 1.64) 
p trend=.324 
















2.25 (1.64, 3.07) 
1.24 (0.91, 1.68) 
2.89 (1.04, 4.08) 
p trend<.001 
1.00 
1.03 (0.70, 1.53) 
0.53 (0.36, 0.78) 
1.50 (0.98, 2.31) 
p trend=.856 
1.00 
1.24 (0.85, 1.80) 
0.65 (0.45, 0.94) 
1.94 (1.29, 2.91) 
p trend=.119 













1.54 (1.15, 2.06) 
2.29 (1.76, 2.97) 
p trend<.001 
1.00 
0.72 (0.50, 1.02) 
1.08 (0.77, 1.52) 
p trend=.648 
1.00  
0.85 (0.60, 1.20) 
1.36 (0.99, 1.88) 
p trend=.064 

















1.43 (1.05, 1.96) 
2.03 (1.49, 2.77) 
2.59 (1.85, 3.62) 
p trend<.001 
1.00 
0.61 (0.42, 0.90) 
1.03 (0.69, 1.51) 
1.23 (0.81, 1.87) 
p trend=.278 
1.00  
0.76 (0.52, 1.10) 
1.12 (0.77, 1.62) 
1.71 (1.15, 2.53) 
p trend=.010 
*    is adjusted for drinking (lifetime intake of spirit-equivalents) and demographics (sex, age, 
education, income)  










Table 2.2 Odds ratios of HCC according to smoking among men 




OR (95% CI)  
Unadjusted 
    (95% CI)  
Adjusted* 
    (95% CI)  
Adjusted** 










1.20 (0.92, 1.56) 
1.00 
0.99 (0.73, 1.33) 
1.00 
1.17 (0.88, 1.55) 














1.04 (.075, 1.44) 
1.33 (0.99, 1.79) 
p trend=.061 
1.00 
0.97 (0.68, 1.37) 
1.01 (0.72, 1.42) 
p trend=.954 
1.00 
1.11 (0.79, 1.56) 
1.23 (0.88, 1.70) 
p trend=.224 
















1.47 (1.04, 2.08) 
0.75 (0.53, 1.05) 
1.75 (1.20, 2.53) 
p trend=.150 
1.00 
1.22 (0.82, 1.82) 
0.57 (0.39, 0.84) 
1.56 (1.02, 2.39) 
p trend=.642 
1.00  
1.41 (0.96, 2.08) 
0.68 (0.47, 0.98) 
1.91 (1.27, 2.86) 
p trend=.114 













0.98 (0.71, 1.36) 
1.38 (1.03, 1.86) 
p trend=.034 
1.00 
0.79 (0.55, 1.13) 
1.19 (0.85, 1.66) 
p trend=.301 
1.00 
0.90 (0.64, 1.28) 
1.42 (1.03, 1.95) 
p trend=.033 

















0.92 (0.65, 1.31) 
1.23 (0.87, 1.31) 
1.57 (1.09, 2.25) 
p trend=.012 
1.00 
0.71 (0.48, 1.04) 
1.07 (0.73, 1.57) 
1.34 (0.89, 2.02) 
p trend=.138 
1.00  
0.83 (0.57, 1.21) 
1.16 (0.80, 1.68) 
1.72 (1.16, 2.54) 
p trend=.008 
*    is adjusted for drinking (lifetime intake of spirit-equivalents) and demographics (age, education, 
income)  















Table 2.3 Logistic model for pack-years (with adjustment) 
  Population Male 
Effect   OR (95% CI) P trend OR (95% CI) P trend 





0.62 (0.42, 0.91) 
1.04 (0.71, 1.54) 
1.22 (0.80, 1.85) 
.278  1.00 
0.71 (0.48, 1.05) 
1.09 (0.74, 1.60) 
1.33 (0.88, 2.01) 
.138 
Education  




2.11 (1.61, 2.76) 
- 1.00 
1.70 (1.27, 2.28) 
 





2.26 (1.73, 2.96) 
- 1.00 
1.87 (1.38, 2.51) 
 
Sex Female  
Male  
1.00 








0.54 (0.33, 0.90) 
0.49 (0.29, 0.82) 
- 1.00 
0.63 (0.36, 1.10) 











1.88 (1.15, 3.07) 
1.77 (1.14, 2.81) 
2.05 (1.26, 3.32) 
0.24 (0.15, 0.40) 
- 1.00 
1.95 (1.20, 3.16) 
1.79 (1.14, 2.82) 
1.94 (1.21, 3.11) 
0.26 (0.16, 0.43) 
 
 
Table 2.4 Logistic model for pack-years (excluding SES factors from adjustment) 
  Population Male 
Effect   OR (95% CI) P trend OR (95% CI) P trend 





0.76 (0.52, 1.10) 
1.12 (0.77, 1.62) 
1.71 (1.15, 2.53) 
.010 1.00 
0.83 (0.57, 1.21) 
1.16 (0.80, 1.68) 
1.72 (1.16, 2.54) 
.008 
Sex Female  
Male  
1.00 








0.39 (0.24, 0.63) 
0.31 (0.19, 0.51) 
- 1.00 
0.46 (0.27, 0.79) 











1.94 (1.20, 3.12) 
1.93 (1.23, 3.01) 
2.00 (1.27, 3.17) 
0.30 (0.19, 0.49) 
- 1.00 
1.99 (1.24, 3.20) 
1.92 (1.23, 3.01) 
1.93 (1.22, 3.05) 







Table 2.5 Odds ratios associated with pack-years of smoking, stratified by education and income level, 
in population 
*OR (95% CI)  
associated with pack-
years of smoking   









 Never  1.00 1.00 1.00 1.00 
 1-17 1.74 (0.94, 3.22) 0.34 (0.11, 1.08) 0.67 (0.31, 1.48) 0.58 (0.01, 0.87) 
 18-31 1.28 (0.69, 2.38) 0.73 (0.26, 2.01) 2.07 (0.69, 6.24) 0.47 (0.20, 1.13) 
 >=32 2.03 (1.13, 3.72) 1.60 (0.64, 3.97) 1.05 (0.34, 3.25) 0.14 (0.01, 1.52) 
* OR adjusted for sex, age, alcohol drinking (spirit-equivalent in lifetime) 
** Quasi-complete data separation detected;  
 
Table 3.1 Odds ratios of HCC according to second-hand smoking among population  




OR (95% CI)  
Unadjusted 
    (95% CI)  
Adjusted* 
    (95% CI)  
Adjusted** 











1.81 (1.44, 2.26) 
1.00 
0.97 (0.72, 1.30) 
1.00 
1.07 (0.81, 1.42) 















2.00 (1.51, 2.66) 
1.62 (1.21, 2.16) 
p trend<.001 
1.00 
1.22 (0.86, 1.74) 
0.73 (0.50, 1.06) 
p trend=.207 
1.00 
1.26 (0.90, 1.77) 
0.88 (0.62, 1.26) 
p trend=.727 
*    is adjusted for drinking (lifetime intake of spirit-equivalents) and demographics (sex, age, 
education, income)  
**    is adjusted for drinking and demographics, excluding education and income 
Table 3.2 Odds ratios of HCC according to second hand smoke exposure among men 




OR (95% CI)  
Unadjusted 
    (95% CI)  
Adjusted* 
    (95% CI) 
 Adjusted** 











1.26 (0.98, 1.63) 
1.00 
1.10 (0.82, 1.48) 
1.00 
1.18 (0.88, 1.58) 















1.50 (1.09, 2.05) 
1.06 (0.78, 1.45) 
p trend=.416 
1.00 
1.47 (1.03, 2.12) 
0.81 (0.56, 1.17) 
p trend=.508 
1.00  
1.49 (1.04, 2.12) 
0.93 (0.65, 1.33) 
p trend=.980 
*    is adjusted for drinking (lifetime intake of spirit-equivalents) and demographics (age, education, 
income)  
**    is adjusted for drinking and demographics, excluding education and income  
